Cargando…

PLGA Nanoparticles Decorated with Anti-HER2 Affibody for Targeted Delivery and Photoinduced Cell Death

The effect of enhanced permeability and retention is often not sufficient for highly effective cancer therapy with nanoparticles, and the development of active targeted drug delivery systems based on nanoparticles is probably the main direction of modern cancer medicine. To meet the challenge, we de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shipunova, Victoria Olegovna, Sogomonyan, Anna Samvelovna, Zelepukin, Ivan Vladimirovich, Nikitin, Maxim Petrovich, Deyev, Sergey Mikhailovich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271481/ https://www.ncbi.nlm.nih.gov/pubmed/34203547 http://dx.doi.org/10.3390/molecules26133955

Ejemplares similares

Two-Step Targeted Drug Delivery via Proteinaceous Barnase-Barstar Interface and Doxorubicin-Loaded Nano-PLGA Outperforms One-Step Strategy for Targeted Delivery to HER2-Overexpressing Cells
por: Komedchikova, Elena N., et al.
Publicado: (2022)

Targeted Two-Step Delivery of Oncotheranostic Nano-PLGA for HER2-Positive Tumor Imaging and Therapy In Vivo: Improved Effectiveness Compared to One-Step Strategy
por: Shipunova, Victoria O., et al.
Publicado: (2023)

Targeting Cancer Cell Tight Junctions Enhances PLGA-Based Photothermal Sensitizers’ Performance In Vitro and In Vivo
por: Shipunova, Victoria O., et al.
Publicado: (2021)

DARPin_9-29-Targeted Gold Nanorods Selectively Suppress HER2-Positive Tumor Growth in Mice
por: Proshkina, Galina M., et al.
Publicado: (2021)

Synthesis and Characterization of Hybrid Core-Shell Fe3O4/SiO2 Nanoparticles for Biomedical Applications
por: Zelepukin, I. V., et al.
Publicado: (2017)

Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo
por: Kovalenko, Vera L., et al.
Publicado: (2022)

Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents
por: Kovalenko, Vera L., et al.
Publicado: (2023)

Comparative Evaluation of Engineered Polypeptide Scaffolds in HER2-Targeting Magnetic Nanocarrier Delivery
por: Shipunova, Victoria O., et al.
Publicado: (2021)

Photothermal Therapy with HER2-Targeted Silver Nanoparticles Leading to Cancer Remission
por: Shipunova, Victoria O., et al.
Publicado: (2022)

Anti-Her2 affibody-decorated arsenene nanosheets induce ferroptosis through depleting intracellular GSH to overcome cisplatin resistance
por: He, Peng, et al.
Publicado: (2023)

3D Models of Cellular Spheroids As a Universal Tool for Studying the Cytotoxic Properties of Anticancer Compounds In Vitro
por: Sogomonyan, A. S., et al.
Publicado: (2022)

Cellular Effects of HER3-Specific Affibody Molecules
por: Göstring, Lovisa, et al.
Publicado: (2012)

Laser Synthesized Core-Satellite Fe-Au Nanoparticles for Multimodal In Vivo Imaging and In Vitro Photothermal Therapy
por: Griaznova, Olga Yu., et al.
Publicado: (2022)

Data on characterization of magnetic nanoparticles stabilized with fusion protein of Barstar and C-term part of Mms6
por: Shipunova, Victoria O., et al.
Publicado: (2018)

Affibody-mediated PET imaging of HER3 expression in malignant tumours
por: Rosestedt, Maria, et al.
Publicado: (2015)

17AAG-induced internalisation of HER2-specific Affibody molecules
por: Göstring, Lovisa, et al.
Publicado: (2016)

Immunomodulatory activity of IR700-labelled affibody targeting HER2
por: Mączyńska, Justyna, et al.
Publicado: (2020)

PET of HER2 Expression with a Novel (18)FAl Labeled Affibody
por: Xu, Yuping, et al.
Publicado: (2017)

Photoinduced edge-specific nanoparticle decoration of two-dimensional tungsten diselenide nanoribbons
por: Murastov, Gennadiy, et al.
Publicado: (2023)

Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer
por: Hu, Xianwen, et al.
Publicado: (2022)

The HER2-Binding Affibody Molecule (Z(HER2∶342))(2) Increases Radiosensitivity in SKBR-3 Cells
por: Ekerljung, Lina, et al.
Publicado: (2012)

Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake
por: Rosestedt, Maria, et al.
Publicado: (2019)

Affibody-Binding Ligands
por: Barozzi, Annalisa, et al.
Publicado: (2020)

Artificial Scaffold Polypeptides As an Efficient Tool for the Targeted Delivery of Nanostructures In Vitro and In Vivo
por: Shipunova, V. O., et al.
Publicado: (2022)

Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules
por: Rinne, Sara S., et al.
Publicado: (2020)

Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution
por: Ding, Haozhong, et al.
Publicado: (2021)

Purification and In Vitro Evaluation of an Anti-HER2 Affibody-Monomethyl Auristatin E Conjugate in HER2-Positive Cancer Cells
por: Damiani, Isabella, et al.
Publicado: (2021)

Prokaryotic expression of antibodies and affibodies
por: Fernández, Luis Angel
Publicado: (2004)

Affibody-DyLight Conjugates for In Vivo Assessment of HER2 Expression by Near-Infrared Optical Imaging
por: Zielinski, Rafal, et al.
Publicado: (2012)

Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111
por: Rinne, Sara S., et al.
Publicado: (2019)

Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with (64)Cu Using NOTA and NODAGA
por: Tolmachev, Vladimir, et al.
Publicado: (2017)

Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy
por: Wang, Haijun, et al.
Publicado: (2021)

Influence of magnetic nanoparticle biotransformation on contrasting efficiency and iron metabolism
por: Yaremenko, Alexey V., et al.
Publicado: (2022)

Pre-Clinical Study of the [(18)F]AlF-Labeled HER2 Affibody for Non-Invasive HER2 Detection in Gastric Cancer
por: Han, Jingya, et al.
Publicado: (2022)

Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2
por: Xu, Tianqi, et al.
Publicado: (2022)

Application of a Novel (68)Ga-HER2 Affibody PET/CT Imaging in Breast Cancer Patients
por: Miao, Haitao, et al.
Publicado: (2022)

The Combined Effect of Nanobubble-IR783-HPPH-Affibody Complex and Laser on HER2-Positive Breast Cancer
por: Cai, Wenbin, et al.
Publicado: (2023)

Porous silicon decorated with Au/TiO(2) nanocomposites for efficient photoinduced enhanced Raman spectroscopy
por: Huang, Sheng-Yang, et al.
Publicado: (2023)

Development of Sulfadiazine-Decorated PLGA Nanoparticles Loaded with 5-Fluorouracil and Cell Viability
por: Guimarães, Pedro Pires Goulart, et al.
Publicado: (2015)

Chemotherapeutic Agents Sensitize Resistant Cancer Cells to the DR5-Specific Variant DR5-B More Efficiently Than to TRAIL by Modulating the Surface Expression of Death and Decoy Receptors
por: Artykov, Artem A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qdao368sq2v4j0ih3284i5s3io